Medicinova inc (MNOV)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13
Operating activities:
Net loss

-2,713

-1,984

-2,378

-3,881

-4,697

-207

-6,779

-3,144

-4,543

-1,602

-3,755

-2,788

-3,016

-1,449

-2,835

-3,199

-3,381

-2,735

-1,607

-2,286

-2,215

-2,380

-2,340

-2,121

-2,352

3,413

-2,236

-2,786

-2,419

Adjustments to reconcile net loss to net cash used in operating activities:
Non-cash stock-based compensation

596

-803

373

1,842

2,699

-1,751

4,728

823

2,530

1,023

1,523

759

1,168

11

1,192

1,329

1,439

881

84

546

513

653

497

231

255

497

197

363

157

Amortization of Kissei upfront payment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-3

Depreciation and amortization

5

5

6

6

6

6

6

6

6

6

6

7

7

3

2

4

4

3

5

8

9

9

9

10

10

9

23

33

33

Gain on disposal of assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0

0

0

4

Change in joint venture investment

-

-

-

-

-

-

-

-

-

0

0

0

-2

-13

-3

-14

-0

-9

-19

-4

-1

-5

7

3

-1

-

-

-

-

Changes in assets and liabilities:
Prepaid expenses and other assets

273

-

-55

398

109

-

-71

-185

289

-137

13

-213

96

-114

-2

-99

41

-131

-143

-240

800

-220

-205

-360

-399

1,322

-87

-178

296

Receivables

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-6,008

-

-

-

-

Accounts payable, accrued liabilities and other liabilities

-493

438

-95

779

-928

388

237

495

-1,786

1,143

318

396

-611

249

51

265

-439

-

-

-

-

-

-

-

-

-

-

-

-

Accounts payable, accrued expenses and deferred rent

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

135

-301

-

-76

82

319

-343

72

-131

-107

Accrued compensation and related expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

119

-440

-

120

112

125

-253

-50

244

18

Net cash used in operating activities

-2,878

-2,404

-2,039

-1,652

-3,029

-1,643

-1,735

-1,653

-4,081

-1,045

-1,919

-1,411

-2,547

-1,058

-1,582

-1,485

-2,419

-1,516

-1,169

-1,232

-3,233

-1,032

-1,590

-1,328

4,768

-4,021

-1,905

-2,097

-2,621

Investing activities:
Acquisition of property and equipment

2

7

0

2

1

-0

0

1

8

-

-

-

-

17

33

11

22

-

-

-

-

0

0

0

3

-

-

-

-

Proceeds from issuance of equity awards under ESPP

-

-

-

-

-

-

-

-

-

-

-

-

-

-

37

0

49

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from issuance of common stock, net of issuance costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

580

-

-

-

2,984

-

-

-

1,628

Net cash used in investing activities

-2

-7

0

-2

-1

0

0

634

-8

-

-

-

-

-17

-33

-11

-22

-

-

-

-

0

0

0

-3

-12

15

-44

4

Financing activities:
Proceeds from sales of property and equipment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

4

Proceeds from issuance of common stock, exercise of common stock options and warrants, net of issuance costs

412

3,331

3,164

180

3,912

1,515

-7

2,243

39,006

4,502

3,551

2,664

1

235

-24

440

7,926

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from issuance of equity under ESPP

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

32

0

57

-

-

3,298

30

71

534

12,751

6

Proceeds from exercise of warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

304

-

-

-

-

Proceeds from issuance of equity awards under ESPP

6

0

10

0

16

-0

23

0

27

0

12

0

65

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by financing activities

418

3,331

3,174

180

3,929

1,515

15

2,243

39,034

4,502

3,564

2,664

66

235

13

440

7,976

-17

16,202

741

638

769

33

40

3,318

71

534

11,129

1,635

Effect of exchange rate changes on cash and cash equivalents

-0

-

-

-

-1

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Effect of exchange rate changes on cash and cash equivalents

-

-

-

-

-

-

0

-1

2

-0

0

0

0

-12

8

3

6

-0

0

-1

-0

-4

-2

-0

0

-

-

-

-

Net change in cash and cash equivalents

-2,462

919

1,135

-1,471

896

-128

-1,720

1,223

34,947

3,456

1,645

1,252

-2,480

-853

-1,593

-1,052

5,541

-1,535

15,031

-492

-2,595

-267

-1,559

-1,287

8,083

-3,960

-1,356

8,988

-981

Supplemental disclosure of cash flow information:
Income taxes paid

-

-

-

-

-

-

-

-

-

0

4

0

5

0

3

0

2

0

3

0

4

0

2

0

2

0

3

0

2